Editorial: The immune infiltrate as a paradigm model to study the biology and novel therapeutic approaches in sarcomas

• Federica Recine,
• Alberto Bongiovanni,
• Laura Mercatali,
• Valentina Fausti,
• Virginia Ferraresi,
• Alessandro De Vita

Affiliations

Federica Recine

Medical Oncology Unit, Azienda Ospedaliera “San Giovanni Addolorata”, Roma, Italy

Alberto Bongiovanni

Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Laura Mercatali

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Valentina Fausti

Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Virginia Ferraresi

Sarcomas and Rare Tumors Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy

Alessandro De Vita

Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy